Tenaya Therapeutics, Inc.

TNYA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$111-$124-$124-$73
Dep. & Amort.$8$9$6$3
Deferred Tax$0$0$0$0
Stock-Based Comp.$17$15$11$3
Change in WC-$8-$6-$1$5
Other Non-Cash$4$4$2$1
Operating Cash Flow-$91-$102-$104-$61
Investing Activities
PP&E Inv.-$1-$1-$21-$25
Net Acquisitions$0$0$0$0
Inv. Purchases-$87-$57-$140-$213
Inv. Sales/Matur.$89$107$245$0
Other Inv. Act.$0-$0$0$0
Investing Cash Flow$1$49$84-$239
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$47$4$77$189
Stock Repurch.$0$0$0-$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$0$0$20
Financing Cash Flow$48$4$78$209
Forex Effect$0$0$0$0
Net Chg. in Cash-$42-$49$57-$90
Supplemental Information
Beg. Cash$46$96$39$129
End Cash$5$46$96$39
Free Cash Flow-$92-$103-$125-$86